SEP 10, 2020 9:00 AM PDT

Congenital Cytomegalovirus - An Unrecognized and Preventable Problem: Fundamentals of Prevention, Diagnosis and Management

Sponsored by: DiaSorin Molecular LLC
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Director of Serology and Virology Division (SAViD), Director Organ and Tissue Donor screening laboratory, Director NSW State Reference Laboratory for HIV, Chair Biosecurity Quality Assurance
    Biography

      William Rawlinson is a clinician scientist recognized internationally for translational research into human CMV in pregnancy and other immune compromised clinical states. He established, and oversees, serology and virology clinical research programs, statewide transplant donor screening, and national quality programs for serology and biosecurity. The laboratory he directs studies pathogenesis of congenital CMV infection, clinical application of research findings to pregnant women and neonates, and novel antivirals. He is conjoint professor at UNSW with over 400 publications in basic research, diagnostic and clinical virology.


    Abstract

    Congenital CMV is the most frequent infectious cause of neonatal malformation in developed nations. It is more prevalent than other neonatal conditions such as spina bifida and Down syndrome. However, this disease has been under-recognized by many health authorities around the world, as well as largely unknown among pregnant women and their partners. Congenital CMV can lead to hearing loss, neurological impairment and even death, however appropriate and timely treatment can minimize the severity and reduce the burden of this disease. This presentation will address the fundamentals of congenital CMV in prevention, diagnosis and management. We will touch on some recent research, and how we can move forward to continue reducing the impact of congenital CMV globally.

    Learning Objectives:

    1. Describe the clinical presentation of congenital CMV

    2. Understand diagnosis and indications for testing and possibilities of screening

    3. Recognize the opportunities for prevention, management and therapeutic strategies

    4. Understand research strategies in development to reduce the global impact of congenital CMV


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    Loading Comments...
    Show Resources
    Attendees
    • See more